Professor John Mattick AO, FAA, FTSE, is an Australian molecular biologist internationally recognised for his blend of ahead-of-its-time genomic research with world renowned leadership of prime research institutes in Australia and around the globe.
Professor Mattick developed the thesis that the majority of the genome of humans and other complex organisms, previously considered to be ‘junk’, is devoted to a vastly expanded regulatory architecture, which is mainly transacted via digital RNA signals and which contains the endogenous program that directs the epigenetic trajectories of differentiation and development.
John has published over 300 research articles and reviews, which have been cited over 70,000 times. His work has received editorial coverage in Nature, Science, Scientific American, New Scientist, and the New York Times.
Professor Mattick was appointed as an Officer in the Order of Australia for his services to molecular biology and genomics, and is an elected Fellow of the Australian Academy of Science, the Australian Academy of Technology and Engineering, and the Australian Academy of Health and Medical Sciences. He is also an Honorary Fellow of the Royal College of Pathologists of Australasia, and most recently Chief Executive of Genomics England.
He was awarded the Centenary Medal by the Australian Government for services to biotechnology and the CSIRO Eureka Prize for Leadership in Science. John was awarded the inaugural Gutenberg Professorship at the Université Louis Pasteur de Strasbourg, and elected as an Associate (Foreign) Member of the European Molecular Biology Organisation, an honour thus far accorded to only 176 individuals worldwide and only 9 Australians.